| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Kymera Therapeutics Inc (NASDAQ: KYMR)
KYMR Technical Analysis
5
| As on 9th Jun 2023 KYMR STOCK Price closed @ 22.75 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 31.38 & Strong Sell for SHORT-TERM with Stoploss of 46.29 we also expect STOCK to react on Following IMPORTANT LEVELS. |
KYMRSTOCK Price
| Open | 23.44 | Change | Price | % |
| High | 23.96 | 1 Day | -0.63 | -2.69 |
| Low | 22.62 | 1 Week | -6.67 | -22.67 |
| Close | 22.75 | 1 Month | -10.20 | -30.96 |
| Volume | 729481 | 1 Year | -31.22 | -57.85 |
| 52 Week High 64.68 | 52 Week Low 14.13 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| KYMR Daily Charts |
KYMR Intraday Charts |
Whats New @ Bazaartrend |
KYMR Free Analysis |
|
|
KYMR Important Levels Intraday
| RESISTANCE | 25.33 |
| RESISTANCE | 24.50 |
| RESISTANCE | 23.99 |
| RESISTANCE | 23.48 |
| SUPPORT | 22.02 |
| SUPPORT | 21.51 |
| SUPPORT | 21.00 |
| SUPPORT | 20.17 |
KYMR Forecast May 2024
| 4th UP Forecast | 75.94 |
| 3rd UP Forecast | 58.88 |
| 2nd UP Forecast | 48.34 |
| 1st UP Forecast | 37.79 |
| 1st DOWN Forecast | 7.71 |
| 2nd DOWN Forecast | -2.84 |
| 3rd DOWN Forecast | -13.38 |
| 4th DOWN Forecast | -30.44 |
KYMR Weekly Forecast
| 4th UP Forecast | 40.73 |
| 3rd UP Forecast | 34.96 |
| 2nd UP Forecast | 31.40 |
| 1st UP Forecast | 27.83 |
| 1st DOWN Forecast | 17.67 |
| 2nd DOWN Forecast | 14.10 |
| 3rd DOWN Forecast | 10.54 |
| 4th DOWN Forecast | 4.77 |
KYMR Forecast2024
| 4th UP Forecast | 125.46 |
| 3rd UP Forecast | 92.52 |
| 2nd UP Forecast | 72.16 |
| 1st UP Forecast | 51.8 |
| 1st DOWN Forecast | -6.3 |
| 2nd DOWN Forecast | -26.66 |
| 3rd DOWN Forecast | -47.02 |
| 4th DOWN Forecast | -79.96 |
Kymera Therapeutics Inc ( NASDAQ USA Symbol : KYMR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
KYMR Business Profile
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; and STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases. The company was founded in 2015 and is headquartered in Watertown, Massachusetts. Address: 200 Arsenal Yards Boulevard, Watertown, MA, United States, 02472
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service